Table 3 Histopathological and molecular subtypes of the patients enrolled in the study

Histological Subtype:

 • Invasive ductal carcinomas (IDC).

 • Invasive lobular carcinomas (ILC).

 • Mixed invasive ductal and lobular carcinomas.

 • Invasive tubular carcinoma (ITC).

Number and percentage

• 36/42 tumors (85.7%)

• 4/42 tumors (9.5%)

• 1/42 tumor (2.4%)

• 1/42 tumor (2.4%)

Biomarker s status of the tumors:

HER2 over-enriched cancers.

HER2-negative/HR–positive cancer

Triple-negative cancers.

Luminal A cancer.

Number and percentage

9/42 were (21.4 %)

17/42 (40.45%)

12 /42 (28.6%)

4/42 (9.5 %)